Suppr超能文献

不同剂量依托咪酯复合舒芬太尼联合氯胺酮静脉诱导对小儿斜视手术眼内压的影响:一项随机临床试验。

Effect of intravenous induction with different doses of Esketamine combined with propofol and sufentanil on intraocular pressure among pediatric strabismus surgery: a randomized clinical trial.

机构信息

Department of Anesthesiology, Tianjin Eye Hospital, 4 Gansu Road, 300020, Tianjin, China.

出版信息

BMC Anesthesiol. 2023 Aug 15;23(1):275. doi: 10.1186/s12871-023-02238-2.

Abstract

BACKGROUND

It is well-established that maintaining stable intraocular pressure (IOP) within the normal range during ophthalmic surgery is important. Esketamine is a commonly used drug in pediatric general anesthesia due to its good analgesic and sedative effects. However, its application in ophthalmic surgery is limited because it can increase IOP. The effect of esketamine combined with other common anesthetics on IOP has been underinvestigated. This study aimed to investigate the effect of different doses of esketamine combined with propofol and sufentanil on IOP during intravenous induction of general anesthesia for pediatric strabismus surgery.

METHODS

A total of 181 children with strabismus undergoing unilateral eye surgery under general anesthesia were recruited. Intravenous induction included the use of sufentanil 0.1 µg/kg, propofol 3 mg/kg, and esketamine. Base on the dosage of esketamine, the patients were randomly allocated into three groups: esketamine low (EL) group with 0.25 mg/kg (n = 62), esketamine high (EH) group with 0.5 mg/kg (n = 60), and normal saline (NS) group (n = 59). Hemodynamic parameters, respiratory parameters, and IOP of the non-surgical eye were recorded and compared among the three groups at different time points: before induction (T), 1 min after induction but before laryngeal mask insertion (T), immediately after laryngeal mask insertion (T), and 2 min after laryngeal mask insertion (T).

RESULTS

There were no significant differences in age, gender, body mass index (BMI), and respiratory parameters among the three groups at T. The IOP at T, T, and T was lower than that at T in all three groups. The EH group (12.6 ± 1.6 mmHg) had a significantly higher IOP than the EL group (12.0 ± 1.6 mmHg) and the NS group (11.6 ± 1.7 mmHg) at T. However, no difference was found between the EL and NS groups at any time point. Systolic blood pressure (SBP) and heart rate (HR) at T, T, and T were lower than at baseline, and SBP and HR were higher at T than at T. Additionally, the EH group had a significantly higher HR at T than the other two groups. There was no significant difference in diastolic blood pressure (DBP) among the three groups at any time point.

CONCLUSION

Propofol combined with sufentanil significantly decreased IOP during the induction of general anesthesia. Although a dose of 0.5 mg/kg esketamine elevated IOP compared to the low-dose and control groups after induction, the IOP remained lower than baseline. 0.25 mg/kg esketamine combined with propofol and sufentanil had little effect on IOP. Therefore, we advocate that a maximum dose of 0.5 mg/kg esketamine combined with propofol and sufentanil will not elevate IOP compared to baseline in pediatric strabismus surgery.

TRIAL REGISTRATION

The registration number is ChiCTR2200066586 at Chictr.org.cn. Registry on 09/12/2022.

摘要

背景

维持眼科手术期间眼内压(IOP)在正常范围内是很重要的,这一点已经得到充分证实。依托咪酯由于其良好的镇痛和镇静作用,是小儿全身麻醉中常用的药物。然而,由于它会升高 IOP,因此其在眼科手术中的应用受到限制。依托咪酯与其他常用麻醉剂联合使用对 IOP 的影响尚未得到充分研究。本研究旨在探讨不同剂量依托咪酯联合丙泊酚和舒芬太尼对小儿斜视手术全身麻醉静脉诱导期间 IOP 的影响。

方法

共纳入 181 例接受全身麻醉单侧眼手术的斜视儿童。静脉诱导包括使用舒芬太尼 0.1μg/kg、丙泊酚 3mg/kg 和依托咪酯。根据依托咪酯的剂量,患者被随机分为三组:依托咪酯低剂量(EL)组 0.25mg/kg(n=62)、依托咪酯高剂量(EH)组 0.5mg/kg(n=60)和生理盐水(NS)组(n=59)。记录三组在不同时间点的非手术眼的血流动力学参数、呼吸参数和 IOP:诱导前(T)、诱导后但喉罩插入前 1 分钟(T)、喉罩插入后即刻(T)和喉罩插入后 2 分钟(T)。

结果

三组在 T 时的年龄、性别、体重指数(BMI)和呼吸参数均无统计学差异。三组在 T、T 和 T 时的 IOP 均低于 T 时。EH 组(12.6±1.6mmHg)在 T 时的 IOP 明显高于 EL 组(12.0±1.6mmHg)和 NS 组(11.6±1.7mmHg)。然而,在任何时间点,EL 组和 NS 组之间的 IOP 均无差异。T、T 和 T 时的收缩压(SBP)和心率(HR)均低于基础值,T 时的 SBP 和 HR 高于 T 时。此外,EH 组在 T 时的 HR 明显高于其他两组。三组在任何时间点的舒张压(DBP)均无统计学差异。

结论

丙泊酚联合舒芬太尼可显著降低全身麻醉诱导期间的 IOP。虽然 0.5mg/kg 依托咪酯的剂量在诱导后与低剂量组和对照组相比升高了 IOP,但 IOP 仍低于基础值。0.25mg/kg 依托咪酯联合丙泊酚和舒芬太尼对 IOP 影响不大。因此,我们主张在小儿斜视手术中,最大剂量 0.5mg/kg 依托咪酯联合丙泊酚和舒芬太尼与基础值相比不会升高 IOP。

试验注册

ChiCTR2200066586 号,于 2022 年 09 月 12 日在 Chictr.org.cn 注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88cb/10426143/484d020af723/12871_2023_2238_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验